DALLAS, June 20, 2019 – Jane E. Freedman, M.D., FAHA, has been selected as the new editor-in-chief of Circulation Research, one of 12 scientific journals of the American Heart Association, the world’s leading voluntary health organization devoted to fighting cardiovascular disease.
Circulation Research, launched in 1953, publishes the highest quality research founded in basic cardiovascular biology, along with translational and clinical research that yields fundamental insights to advance the understanding of the mechanisms of disease and therapies.
“I’m thrilled and honored to take on this role and I look forward to working with our new editorial board in broadening our scientific scope and having greater interface with early and mid-career scientist and even consumer audiences,” Freedman said, who shared some of the early plans for the journal in an editorial in her first issue. “I’m continually fascinated, learning new things every day as I read through the submitted studies and it’s exciting to know that the science we’re publishing today could likely be the practiced medical discoveries of tomorrow.”
Freedman is the Director of Translational Research at the University of Massachusetts Memorial Heart & Vascular Center and a Professor of Medicine at the UMass Medical School in Worcester. Her main research interests include inflammation and immunity in cardiovascular thrombosis, as well as gene expression and extracellular RNAs as biomarkers and modulators of heart disease and stroke. She has led numerous large research projects, spoken at universities and conferences worldwide and published over 150 papers in leading medical journals.
Freedman has served on the editorial board of Circulation Research since 1998 and was previously an associate and senior editor for the American Heart Association’s flagship journal, Circulation. She’s held several other editorial positions with leading journals in the field of cardiovascular research.
“We enthusiastically endorse the selection of Dr. Freedman as the Editor-in-Chief of Circulation Research. Along with her editorial experience, she’s an active member of the Association’s Arteriosclerosis, Thrombosis and Vascular Biology Council and is a highly respected investigator and clinician,” said Mark Estes, M.D., chair of the American Heart Association’s Scientific Publishing Committee and Professor of Medicine at the New England Cardiac Arrhythmia Center at Tufts University School of Medicine in Boston. “She will work collaboratively with her outstanding Editorial Board with the full support of the AHA staff and the Scientific Publishing Committee to ensure that Circulation Research remains the premier journal for publication of the best basic and translational science.”
“With such a long and rich history, Circulation Research continues to be the preeminent journal for the basic and translational cardiovascular and stroke research community,” Freedman said. “The new editorial team will solidify the publication’s position as the unequivocal leader in the ever-broadening field of the basic cardiovascular sciences. Our goal is to ensure this journal is the place to find and publish the highest impact and reliable research, while promoting inclusivity, quality and integrity.”
Freedman plans to initiate a regular podcast series and more interaction on social media, including Twitter, Instagram and Facebook. Follow Circulation Research at:
- Twitter: @CircRes https://twitter.com/CircRes
- Instagram: @CircRes https://www.instagram.com/CircRes/
- Facebook: @CircRes https://www.facebook.com/CircRes
Selected for the Circulation Research editorship last fall after a lengthy international search for the journal’s next editor, Freedman’s inaugural issue publishes online today.
- Available multimedia is on right column of release link – https://newsroom.heart.org/news/circulation-research-names-new-editor?preview=59678c4aed898e187beb1e0e5f769c22
- Follow AHA/ASA news on Twitter @HeartNews
The American Heart Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.
The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
Cathy Lewis: 214-706-1324; firstname.lastname@example.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)